Yair Holtzman, director of Global Life Sciences at the consulting firm WTP Advisors in White Plains, N.Y., analyzed and discussed the strengths, weaknesses and opportunities of the device industry in The U.S. Medical Device Industry in 2012: Challenges at Home and Abroad.
Although U.S.-based medical device companies dominate the industry, there are still several weaknesses, including the FDA review process, a planned excise tax on device makers as part of the healthcare reform law and globalization.
To read the full study, click here.
More Articles on Medical Devices:
Wright Medical Filed Petition to Block Smith & Nephews Metal Implant
Breg Appoints Former Integra LifeSciences Exec to Board
FH Orthopedics Receives CE Mark Approval for Cervical Elastic Spine Disc
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.